BNP Paribas Financial Markets’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $59.6K | Sell |
7,117
-346,712
| -98% | -$2.9M | ﹤0.01% | 4802 |
|
|
2026
Q1 | $2.94M | Buy |
353,829
+293,468
| +486% | +$3.04M | ﹤0.01% | 2425 |
|
|
2025
Q4 | $746K | Buy |
60,361
+49,419
| +452% | +$530K | ﹤0.01% | 3313 |
|
|
2025
Q3 | $96.5K | Buy |
10,942
+6,246
| +133% | +$48.6K | ﹤0.01% | 4311 |
|
|
2025
Q2 | $30K | Sell |
4,696
-22,653
| -83% | -$130K | ﹤0.01% | 4445 |
|
|
2025
Q1 | $133K | Buy |
27,349
+26,904
| +6,046% | +$223K | ﹤0.01% | 3926 |
|
|
2024
Q4 | $4.25K | Sell |
445
-31,025
| -99% | -$285K | ﹤0.01% | 4950 |
|
|
2024
Q3 | $263K | Sell |
31,470
-58,544
| -65% | -$532K | ﹤0.01% | 3149 |
|
|
2024
Q2 | $614K | Sell |
90,014
-73,575
| -45% | -$317K | ﹤0.01% | 2557 |
|
|
2024
Q1 | $414K | Buy |
163,589
+99,520
| +155% | +$224K | ﹤0.01% | 2950 |
|
|
2023
Q4 | $154K | Buy |
64,069
+35,869
| +127% | +$84.3K | ﹤0.01% | 3294 |
|
|
2023
Q3 | $95.9K | Sell |
28,200
-90,780
| -76% | -$503K | ﹤0.01% | 3340 |
|
|
2023
Q2 | $875K | Sell |
118,980
-49,366
| -29% | -$458K | ﹤0.01% | 2289 |
|
|
2023
Q1 | $1.74M | Buy |
168,346
+53,481
| +47% | +$646K | ﹤0.01% | 1916 |
|
|
2022
Q4 | $1.36M | Buy |
114,865
+13,018
| +13% | +$201K | ﹤0.01% | 1983 |
|
|
2022
Q3 | $2.14M | Buy |
101,847
+29,733
| +41% | +$827K | ﹤0.01% | 1917 |
|
|
2022
Q2 | $2.24M | Sell |
72,114
-7,839
| -10% | -$268K | ﹤0.01% | 1689 |
|
|
2022
Q1 | $3.28M | Sell |
79,953
-59,344
| -43% | -$2.62M | ﹤0.01% | 1515 |
|
|
2021
Q4 | $6.06M | Buy |
139,297
+109,726
| +371% | +$4.96M | 0.01% | 1230 |
|
|
2021
Q3 | $1.48M | Sell |
29,571
-4,068
| -12% | -$246K | ﹤0.01% | 2106 |
|
|
2021
Q2 | $2.12M | Buy |
33,639
+16,730
| +99% | +$1.07M | ﹤0.01% | 1724 |
|
|
2021
Q1 | $1.57M | Sell |
16,909
-11,424
| -40% | -$1.17M | ﹤0.01% | 1844 |
|
|
2020
Q4 | $2.54M | Buy |
28,333
+19,864
| +235% | +$1.82M | ﹤0.01% | 1501 |
|
|
2020
Q3 | $875K | Buy |
8,469
+2,590
| +44% | +$279K | ﹤0.01% | 1885 |
|
|
2020
Q2 | $465K | Sell |
5,879
-20,165
| -77% | -$1.5M | ﹤0.01% | 2132 |
|
|
2020
Q1 | $1.51M | Buy |
26,044
+14,840
| +132% | +$855K | ﹤0.01% | 1645 |
|
|
2019
Q4 | $604K | Buy |
11,204
+2,952
| +36% | +$160K | ﹤0.01% | 2335 |
|
|
2019
Q3 | $431K | Buy |
8,252
+2,181
| +36% | +$102K | ﹤0.01% | 2294 |
|
|
2019
Q2 | $293K | Sell |
6,071
-8,157
| -57% | -$391K | ﹤0.01% | 2362 |
|
|
2019
Q1 | $719K | Buy |
14,228
+12,767
| +874% | +$753K | ﹤0.01% | 1874 |
|
|
2018
Q4 | $86.6K | Sell |
1,461
-5,122
| -78% | -$330K | ﹤0.01% | 2434 |
|
|
2018
Q3 | $433K | Buy |
6,583
+1,867
| +40% | +$109K | ﹤0.01% | 2083 |
|
|
2018
Q2 | $238K | Sell |
4,716
-6,384
| -58% | -$333K | ﹤0.01% | 2361 |
|
|
2018
Q1 | $584K | Sell |
11,100
-23,284
| -68% | -$1.16M | ﹤0.01% | 2106 |
|
|
2017
Q4 | $1.6M | Buy |
34,384
+16,340
| +91% | +$688K | ﹤0.01% | 1627 |
|
|
2017
Q3 | $730K | Buy |
18,044
+7,403
| +70% | +$268K | ﹤0.01% | 1764 |
|
|
2017
Q2 | $361K | Buy |
10,641
+3,554
| +50% | +$110K | ﹤0.01% | 2096 |
|
|
2017
Q1 | $206K | Buy |
7,087
+694
| +11% | +$21.1K | ﹤0.01% | 2197 |
|
|
2016
Q4 | $210K | Buy |
6,393
+1,231
| +24% | +$36.9K | ﹤0.01% | 2179 |
|
|
2016
Q3 | $163K | Sell |
5,162
-4,644
| -47% | -$135K | ﹤0.01% | 1855 |
|
|
2016
Q2 | $276K | Buy |
9,806
+5,255
| +115% | +$206K | ﹤0.01% | 1781 |
|
|
2016
Q1 | $165K | Sell |
4,551
-1,479
| -25% | -$52.2K | ﹤0.01% | 1609 |
|
|
2015
Q4 | $241K | Sell |
6,030
-368
| -6% | -$12.8K | ﹤0.01% | 1806 |
|
|
2015
Q3 | $182K | Buy |
6,398
+3,873
| +153% | +$128K | ﹤0.01% | 2017 |
|
|
2015
Q2 | $83.2K | Buy |
2,525
+1,825
| +261% | +$56.6K | ﹤0.01% | 2183 |
|
|
2015
Q1 | $20.1K | Buy |
+700
| New | +$20.1K | ﹤0.01% | 2361 |
|
|
2014
Q4 | – | Sell |
-1,816
| Closed | -$38.7K | – | 2316 |
|
|
2014
Q3 | $38.7K | Buy |
1,816
+1,804
| +15,033% | +$41.3K | ﹤0.01% | 2743 |
|
|
2014
Q2 | $270 | Sell |
12
-73
| -86% | -$1.7K | ﹤0.01% | 3674 |
|
|
2014
Q1 | $2.24K | Sell |
85
-313
| -79% | -$7.91K | ﹤0.01% | 2621 |
|
|
2013
Q4 | $9.15K | Buy |
+398
| New | +$8.3K | ﹤0.01% | 2700 |
|
Other funds holding EBS
OHA
BNP Paribas Financial Markets's EBS Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Emergent Biosolutions (EBS) stake by 98% in Q2 2026, selling an estimated $2.9M and leaving 7,117 shares worth $59.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4802.
BNP Paribas Financial Markets first reported a position in EBS in Q4 2013 and has held it in 50 quarters since. The position peaked at $6.06M in Q4 2021. 180 funds tracked by Wall St. Rank hold EBS as of Q2 2026.
- BNP Paribas Financial Markets held 7,117 shares of Emergent Biosolutions worth $59.6K as of Q2 2026.
- BNP Paribas Financial Markets sold 346,712 Emergent Biosolutions shares in Q2 2026, an estimated $2.9M.
- Emergent Biosolutions made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4802 holding.
- BNP Paribas Financial Markets first reported a position in Emergent Biosolutions in Q4 2013 and has held it in 50 quarters since.
- BNP Paribas Financial Markets's Emergent Biosolutions position peaked at $6.06M in Q4 2021.
- 180 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.